Top compounds associated with response to ADAMTS2


Feature Type Standardized
Nominal ANOVA
mRNA clofarabine CTRPv2 pan-cancer AAC -0.12 8e-05
mRNA navitoclax:gemcitabine (1:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 8e-05
mRNA GSK269962A GDSC1000 pan-cancer AAC 0.13 0.0001
mRNA Gefitinib GDSC1000 pan-cancer AAC -0.13 0.0001
mRNA TG-101348 CTRPv2 pan-cancer AAC 0.13 0.0001
mRNA selumetinib:vorinostat (8:1 mol/mol) CTRPv2 pan-cancer AAC -0.14 0.0001
mRNA selumetinib:decitabine (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.13 0.0001
mRNA austocystin d CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA niclosamide CTRPv2 pan-cancer AAC -0.14 0.0002
mRNA BRD-K04800985 CTRPv2 pan-cancer AAC 0.15 0.0002
Download CSV